Filing Details

Accession Number:
0001127602-17-000737
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-04 17:26:55
Reporting Period:
2017-01-03
Filing Date:
2017-01-04
Accepted Time:
2017-01-04 17:26:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1675905 Joseph David Gaffin 852 Winter Street
Waltham MA 02451
Svp, Clo, Alkermes, Inc. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2017-01-03 2,250 $15.95 27,207 No 4 M Direct
Ordinary Shares Acquisiton 2017-01-03 250 $14.13 27,457 No 4 M Direct
Ordinary Shares Disposition 2017-01-03 2,500 $55.40 24,957 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (Right to Buy) Disposition 2017-01-03 2,250 $0.00 2,250 $15.95
Ordinary Shares Employee Stock Option (Right to Buy) Disposition 2017-01-03 250 $0.00 250 $14.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,250 2017-06-01 No 4 M Direct
250 2017-11-05 No 4 M Direct
Footnotes
  1. This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. These options are fully vested in accordance with their terms.